| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233282 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 7 Pages |
Abstract
In the largest retrospective analysis of uterine sarcoma published thus far, AR conferred a 53% reduction in the risk of LRF at 5 years. Use of AR may have broader indications than what are currently accepted in clinical practice.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sagus M.D., Timothy E. Ph.D., Janice K. M.D., Jeffrey Y.C. M.D.,